High cost of new cancer drugs may lead to lower medical adherence

05/23/2011 | Wall Street Journal, The

Spending to treat cancer is likely to rise 15% annually through 2013, according to Medco's Drug Trend Report, primarily due to more expensive drugs. Some 10% of patients already fail to fill new prescriptions for oral cancer treatments, according to a study by Avalere Health and The West Clinic, and higher drug costs could lead to higher prescription abandonment rates. The study authors suggest that policymakers find ways to minimize out-of-pocket costs for low-income patients.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ